{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:27:44Z","timestamp":1789597664773,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.euo.2020.11.005","type":"journal-article","created":{"date-parts":[[2020,12,5]],"date-time":"2020-12-05T07:50:03Z","timestamp":1607154603000},"page":"792-801","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["Incidence and Survival Rates of Contemporary Patients with Invasive Upper Tract Urothelial Carcinoma"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8110-7341","authenticated-orcid":false,"given":"Claudia","family":"Coll\u00e0 Ruvolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Nocera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Franziska","family":"Stolzenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Wenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"Cucchiara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Montorsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Mirone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre I.","family":"Karakiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2020.11.005_bib0005","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.euo.2020.11.005_bib0010","doi-asserted-by":"crossref","unstructured":"Roupr\u00eat M., Babjuk M., Burger M., et al. European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2020 update. Eur Urol. In press. https:\/\/doi.org\/10.1016\/j.eururo.2020.05.042.","DOI":"10.1016\/j.eururo.2020.05.042"},{"key":"10.1016\/j.euo.2020.11.005_bib0015","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00345-012-0877-2","article-title":"Upper urinary tract urothelial cell carcinoma: location as a predictive factor for concomitant bladder carcinoma","volume":"31","author":"Cosentino","year":"2013","journal-title":"World J Urol"},{"key":"10.1016\/j.euo.2020.11.005_bib0020","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00345-010-0594-7","article-title":"Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma","volume":"29","author":"Shariat","year":"2011","journal-title":"World J Urol"},{"key":"10.1016\/j.euo.2020.11.005_bib0025","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/cncr.24135","article-title":"Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration","volume":"115","author":"Margulis","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.euo.2020.11.005_bib0030","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1464-410X.2010.09675.x","article-title":"Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973\u20132005: outcomes for UTUC over the past 30 years","volume":"107","author":"Raman","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2020.11.005_bib0035","doi-asserted-by":"crossref","first-page":"e2186","DOI":"10.1016\/S2666-1683(20)34080-5","article-title":"Trends in incidence and survival of upper Urinary Tract Urothelial Carcinoma (UTUC) diagnosed between 1993\u20132017 in the Netherlands: a study on 13,438 patients","volume":"19","author":"van Doeveren","year":"2020","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.euo.2020.11.005_bib0040","doi-asserted-by":"crossref","first-page":"E107","DOI":"10.1111\/bju.12025","article-title":"Prognosis is deteriorating for upper tract urothelial cancer: data for England 1985\u20132010: deteriorating prognosis for UTUC","volume":"112","author":"Eylert","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2020.11.005_bib0045","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.urology.2009.05.013","article-title":"Incidences of kidney, pelvis, ureter, and bladder cancer in a nationwide, population-based cancer registry, Denmark, 1944\u20132003","volume":"75","author":"Wihlborg","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.euo.2020.11.005_bib0050","unstructured":"SEER. About the SEER program. https:\/\/seer.cancer.gov\/about\/overview.html."},{"key":"10.1016\/j.euo.2020.11.005_bib0055","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.eururo.2011.12.055","article-title":"Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma","volume":"61","author":"Rink","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2020.11.005_bib0060","article-title":"Cisplatin-based combination chemotherapy in septuagenarians with metastatic urothelial cancer","volume":"32","author":"Galsky","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euo.2020.11.005_bib0065","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/annonc\/mdi039","article-title":"The outcome of elderly patients with advanced urothelial carcinoma after platinum-based combination chemotherapy","volume":"16","author":"Bamias","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.euo.2020.11.005_bib0070","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1200\/JCO.2004.08.039","article-title":"Outcome of elderly patients with recurrent or metastatic head and neck cancer treated with cisplatin-based chemotherapy","volume":"22","author":"Argiris","year":"2004","journal-title":"JCO"},{"key":"10.1016\/j.euo.2020.11.005_bib0075","first-page":"155","article-title":"Clinical outcomes following neoadjuvant cisplatin-based chemotherapy for bladder cancer in elderly compared with younger patients: outcome post-neoadjuvant chemotherapy in elderly","volume":"24","author":"Chau","year":"2015","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.1016\/j.euo.2020.11.005_bib0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.clgc.2019.10.008","article-title":"Bladder cancer stage development, 2004\u20132014 in Europe compared with the United States: analysis of European population-based cancer registries, the United States SEER Database, and a large tertiary institutional cohort","volume":"18","author":"Schulz","year":"2020","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.euo.2020.11.005_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eururo.2011.03.047","article-title":"Trends in mortality from urologic cancers in Europe, 1970\u20132008","volume":"60","author":"Bosetti","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2020.11.005_bib0090","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s00345-017-2026-4","article-title":"Trends of lymphadenectomy in upper tract urothelial carcinoma (UTUC) patients treated with radical nephroureterectomy","volume":"35","author":"Moschini","year":"2017","journal-title":"World J Urol"},{"key":"10.1016\/j.euo.2020.11.005_bib0095","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.eururo.2009.06.004","article-title":"The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed?","volume":"56","author":"Roscigno","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2020.11.005_bib0100","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.eururo.2011.07.009","article-title":"Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer","volume":"60","author":"Roscigno","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2020.11.005_bib0105","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1016\/j.clgc.2018.09.017","article-title":"Survival effect of chemotherapy in metastatic upper urinary tract urothelial carcinoma","volume":"17","author":"Nazzani","year":"2019","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.euo.2020.11.005_bib0110","doi-asserted-by":"crossref","first-page":"e602","DOI":"10.1016\/j.clgc.2019.03.003","article-title":"Survival effect of nephroureterectomy in metastatic upper urinary tract urothelial carcinoma","volume":"17","author":"Nazzani","year":"2019","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.euo.2020.11.005_bib0115","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.21037\/tau-20-605","article-title":"Marital status impacts survival in patients with upper tract urothelial carcinoma: a population-based, propensity-matched study","volume":"9","author":"Wang","year":"2020","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.euo.2020.11.005_bib0120","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.eururo.2010.07.003","article-title":"The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center","volume":"58","author":"Favaretto","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2020.11.005_bib0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2018.12.002","article-title":"Preoperative multiplex nomogram for prediction of high-risk nonorgan-confined upper-tract urothelial carcinoma","volume":"37","author":"Petros","year":"2019","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euo.2020.11.005_bib0130","series-title":"Impact of lymph node dissection in the management of high-risk primary upper tract urothelial carcinoma patients. clinicaltrials.gov","author":"Li","year":"2017"},{"key":"10.1016\/j.euo.2020.11.005_bib0135","unstructured":"Xue W., Zhou L. Prognostic value of lymph node dissection in patients with transitional cell carcinoma of the upper urinary tract. Full text view. ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03474926."},{"key":"10.1016\/j.euo.2020.11.005_bib0140","series-title":"Feasibility and safety of extraperitoneal laparoscopic extended retroperitoneal lymph node dissection at time of nephroureterectomy for upper tract urothelial carcinoma. clinicaltrials.gov","author":"RenJi Hospital","year":"2018"},{"key":"10.1016\/j.euo.2020.11.005_bib0145","series-title":"Merits of performing a modified template retroperitoneal lymph node dissection at time of nephroureterectomy for urothelial carcinoma of the upper urinary tract. clinicaltrials.gov","author":"H. Lee Moffitt Cancer Center and Research Institute","year":"2017"},{"key":"10.1016\/j.euo.2020.11.005_bib0150","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0140-6736(20)30415-3","article-title":"Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial","volume":"395","author":"Birtle","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.euo.2020.11.005_bib0155","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/JU.0000000000000644","article-title":"Phase II trial of neoadjuvant systemic chemotherapy followed by extirpative surgery in patients with high grade upper tract urothelial carcinoma","volume":"203","author":"Margulis","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2020.11.005_bib0160","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.eururo.2020.04.008","article-title":"Re: phase II trial of neoadjuvant systemic chemotherapy followed by extirpative surgery in patients with high grade upper tract urothelial carcinoma","volume":"78","author":"Califano","year":"2020","journal-title":"Eur Urol"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931120301814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931120301814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:47:29Z","timestamp":1762876049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931120301814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S2588931120301814"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2020.11.005","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and Survival Rates of Contemporary Patients with Invasive Upper Tract Urothelial Carcinoma","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2020.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}